Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Decreased dopamine activity predicts relapse in methamphetamine abusers.

Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS.

Mol Psychiatry. 2012 Sep;17(9):918-25. doi: 10.1038/mp.2011.86. Epub 2011 Jul 12.

2.

Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.

Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D.

Neuroimage. 2015 Nov 1;121:20-8. doi: 10.1016/j.neuroimage.2015.07.035. Epub 2015 Jul 21.

PMID:
26208874
3.

Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.

Ballard ME, Dean AC, Mandelkern MA, London ED.

PLoS One. 2015 Dec 14;10(12):e0143510. doi: 10.1371/journal.pone.0143510. eCollection 2015.

4.
5.

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.

Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS.

Am J Psychiatry. 2004 Feb;161(2):242-8.

PMID:
14754772
6.

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J.

J Neurosci. 2001 Dec 1;21(23):9414-8.

7.

Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.

Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED.

Int J Neuropsychopharmacol. 2015 Jan 20;18(7):pyu119. doi: 10.1093/ijnp/pyu119.

8.

Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later.

Asensio S, Romero MJ, Romero FJ, Wong C, Alia-Klein N, Tomasi D, Wang GJ, Telang F, Volkow ND, Goldstein RZ.

Synapse. 2010 May;64(5):397-402. doi: 10.1002/syn.20741.

9.

Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers.

Wiers CE, Shokri-Kojori E, Cabrera E, Cunningham S, Wong C, Tomasi D, Wang GJ, Volkow ND.

Neurosci Lett. 2016 Mar 23;617:27-31. doi: 10.1016/j.neulet.2016.01.056. Epub 2016 Jan 29.

10.

Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA.

J Neurosci. 2009 Nov 25;29(47):14734-40. doi: 10.1523/JNEUROSCI.3765-09.2009.

11.

Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J, Jayne M, Wong C, Tomasi D.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3149-56. doi: 10.1073/pnas.1411228111. Epub 2014 Jul 14.

12.

Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH.

Neuropsychopharmacology. 2013 Oct;38(11):2179-87. doi: 10.1038/npp.2013.115. Epub 2013 May 9.

13.

Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.

Wiers CE, Shumay E, Cabrera E, Shokri-Kojori E, Gladwin TE, Skarda E, Cunningham SI, Kim SW, Wong TC, Tomasi D, Wang GJ, Volkow ND.

Transl Psychiatry. 2016 Mar 8;6:e752. doi: 10.1038/tp.2016.14.

14.

Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.

Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.

Neuroimage. 2013 Nov 15;82:252-9. doi: 10.1016/j.neuroimage.2013.05.091. Epub 2013 May 28.

PMID:
23727314
15.

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.

McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA.

Synapse. 2008 Feb;62(2):91-100.

PMID:
17992686
16.

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.

Neurobiol Dis. 2011 Jun;42(3):391-403. doi: 10.1016/j.nbd.2011.01.033. Epub 2011 Feb 15.

PMID:
21303698
17.

Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.

Arch Gen Psychiatry. 2007 Aug;64(8):932-40.

PMID:
17679638
18.

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N.

Am J Psychiatry. 2001 Dec;158(12):2015-21.

PMID:
11729018
19.

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR.

Psychopharmacology (Berl). 2006 Apr;185(3):327-38. Epub 2006 Mar 3. Erratum in: Psychopharmacology (Berl). 2006 Jul;186(4):620.

20.

Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats.

Kousik SM, Napier TC, Ross RD, Sumner DR, Carvey PM.

J Pharmacol Exp Ther. 2014 Nov;351(2):432-9. doi: 10.1124/jpet.114.217802. Epub 2014 Sep 2.

Supplemental Content

Support Center